Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer
Phase of Trial: Phase I/II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Cetuximab (Primary) ; Zirconium-89 cetuximab (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms IMPACT-CRC
- 21 Sep 2017 NCT reports planned patient number 85 Eudra reports 151 kept Higher number.
- 01 Aug 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated